JD Health International Inc. (06618) released its monthly return, covering the period ended 31 January 2026 and submitted on 5 February 2026. The total authorized share capital remains at 100,000,000,000 ordinary shares, each with a par value of USD 0.0000005, amounting to USD 50,000. The number of issued shares stands at 3,209,275,111, showing no change from the previous month, and the minimum public float requirement of 25% was confirmed to have been met.

According to the share option data, the Pre-IPO ESOP saw 5,670 options lapse, bringing the outstanding options to 11,193,440. No new shares were issued under the Pre-IPO ESOP, while the Post-IPO Share Option Scheme’s outstanding balance for potential new shares is 312,708,211. Under the Post-IPO Share Award Scheme, 16,692,802 shares are available for issuance or transfer, with no new shares issued during the period. No treasury shares were involved and no changes occurred in total issued shares.